Jenny J. Li, MD, GRACE Guest Faculty

Jenny J. Li, MD, Hematology/Oncology Fellow
Mayo Clinic
Rochester
MN
Specialties
Hematology, Oncology

Dr. Jenny Jing Li is originally from China. She earned her undergraduate degree from Duke University where she majored in neuroscience and biology. She received her M.D. degree from Duke University School of Medicine and completed her Internal Medicine residency at University of Texas Southwestern Medical Center. She is currently undergoing her hematology/oncology fellowship training at Mayo Clinic in Rochester, MN

Conflict of Interest

None

 

Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community.

In this video, Dr. Li discusses which patients with advanced NSCLC are good candidates for first line immunotherapy alone today.

******

李仁妮博士加入GRACE,担任客座教授,为普通话社区提供最新信息给我们的普通话肺癌视频库。 在此视频中,李医生讨论了哪些晚期NSCLC患者今天仅是一线免疫治疗的好人选。

 

 

 

Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community.

In this video, Dr. Li discusses the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today. 

To join the conversation, visit https://cancergrace.org/forum.

*******

Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community.

In this video, Dr. Li shares information on the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced non-squamous NSCLC today.

李仁妮博士加入GRACE,担任客座教授,为普通话社区提供最新信息给我们的普通话肺癌视频库。 在此视频中,李博士分享了有关低PD-L1肿瘤表达或低水平NSCLC晚期患者的主要治疗选择的信息。

To join the conversation, visit https://cancergrace.org/forum.

Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community.

In this video, Dr. Li shares information on the leading treatment options for patients with advanced NSCLC and high tumor PD-L1 expression.

To join the conversation, visit https://cancergrace.org/forum.

李仁妮博士加入GRACE,担任客座教授,为普通话社区提供最新信息给我们的普通话肺癌视频库。 在此视频中,李医生分享了晚期NSCLC和高肿瘤PD-L1表达患者的主要治疗选择的信息。

Forum Discussions

Original post date: 2022-02-21

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12
Original post date: 2022-02-01

Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder.  Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the

Last Activity: Tue, 02/01/2022 - 16:16
Original post date: 2021-11-24

The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!

Image
Happy Thanksgiving!
Last Activity: Thu, 12/02/2021 - 15:33
Original post date: 2021-01-07
The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about

Last Activity: Thu, 01/07/2021 - 15:55

Comments

Post Date: 2022-04-12

You may find our clinical trial page helpful, also.  https://cancergrace.org/find-clinical-trials.  

Post Date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 


This comment has been promoted to its

Post Date: 2021-12-02

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that

Post Date: 2021-07-19

Hi all!  

The 2021 Targeted Therapies Patient Forum is now available ON Demand!  

Click below to